Arsenal Advisors

At ARSENAL, we specialize in transforming businesses by harnessing the power of innovation to create markets and launch products.

[Arsenal Advisors @ArsenalAdvisors]

2025 has been a tough year for biopharma. Is it about to explode or implode- we dive in- https://t.co/c2CgRVpbav

[Arsenal Advisors @ArsenalAdvisors]

According to industry trends, companies that adopt an omnichannel marketing strategy see an average increase of 18.96% in their annual revenue, compared to those that use single or multichannel strategies.

Read more 👉 https://t.co/TJyq1ll1uS

#GreaterCustomerSatisfaction

[Arsenal Advisors @ArsenalAdvisors]

Consulting, “Omnichannel Marketing in Pharma: A Novel Approach for Engaging Patients and Physicians”,

Read the full article: The Evolution of Pharmaceutical Marketing: From Multichannel to Omnichannel
▸ https://t.co/MFUgHkzSMj

#GreaterCustomerSatisfaction #PharmaIndustry

[Arsenal Advisors @ArsenalAdvisors]

KOLs play a pivotal role in the pharma industry, influencing the opinions of healthcare professionals and patients, shaping clinical treatment and referral networks, and driving drug product adoption.

Read the full article:
▸ https://t.co/K7YqqsvT0e

#KeyOpinionLeaders

[Arsenal Advisors @ArsenalAdvisors]

Omnichannel marketing in the pharmaceutical industry is a marketing strategy that involves integrating multiple channels to create a seamless and personalized customer experience.

Read more 👉 https://t.co/oIv7UoOASs

#GreaterCustomerSatisfaction #PharmaIndustry

[Arsenal Advisors @ArsenalAdvisors]

KOLs have the potential to share valuable information about the latest research, clinical trials, and patient care that can help pharmaceutical companies to effectively navigate the complex regulatory landscape.

Read more 👉 https://t.co/V2viNAhPuN

#KeyOpinionLeaders

[Arsenal Advisors @ArsenalAdvisors]

Omnichannel marketing benefits pharmaceutical companies by enabling them to reach wider audiences, engage customers in a personalized way, and improve the overall customer experience.

Read more 👉 https://t.co/Cw4cave0z9

#GreaterCustomerSatisfaction #PharmaIndustry

[Arsenal Advisors @ArsenalAdvisors]

The Evolution of Pharmaceutical Marketing: From Multichannel to Omnichannel
▸ https://t.co/msWKPlokYM

#GreaterCustomerSatisfaction #PharmaIndustry #OmnichannelMarketing #DigitalMarketing

[Arsenal Advisors @ArsenalAdvisors]

How The Best Pharma Companies Leverage The Power of KOLs (Key Opinion Leaders): https://t.co/5iOqBOMGFP

#KeyOpinionLeaders #TransformingPharma #DigitalTransformationJourney

[Arsenal Advisors @ArsenalAdvisors]

https://t.co/lgBsAODy9D

[@ayakatally.bsky.social @AYakatally]

social media managers telling the design team what to do:

[Arsenal Advisors @ArsenalAdvisors]

Join us this Thursday if you can. We are uploading HCP conversations into tools that reveal insights beyond what they said... it's about HOW they said it. Check it out $pfe $nbix $nvs #customerjourney

https://t.co/95YG6wEYZm

[Arsenal Advisors @ArsenalAdvisors]

Every Monday, Wednesday, and Friday we deliver breaking industry news through our AI powered newsletter.

Read more 👉 https://t.co/i4gik0UnJB

#arsenaladvisors #LifeScienceCompanies #DigitalMarketing #ChronicHealthConditions

[Arsenal Advisors @ArsenalAdvisors]

Thinking about a biotech or pharma product launch? Our CEO, Frank Dolan, spoke with Bozidar Jovicevic on the Pharma Launch Secrets Podcast, sharing experiences from over a dozen launches.

#pharmalaunch #firstinclassmedication #pharmamarketing

[Arsenal Advisors @ArsenalAdvisors]

https://t.co/DYQu02TQK2

[Arsenal Advisors @ArsenalAdvisors]

This renaissance has also left an indelible mark on Life Science companies

Read more 👉 https://t.co/KJSRNcHQJW

#arsenaladvisors #LifeScienceCompanies #DigitalMarketing #ChronicHealthConditions

[Arsenal Advisors @ArsenalAdvisors]

https://t.co/tYFYpeNRPc

[Ned Pagliarulo @NedPagliarulo]

FDA advisory committee VOTE on whether available trial evidence is sufficient to support approval of $AMLX's ALS drug:

YES - 7
NO - 2

[Arsenal Advisors @ArsenalAdvisors]

Replay of Faculty Briefing for the Sept Transformation Summit https://t.co/o13pwc18VK

[Arsenal Advisors @ArsenalAdvisors]

Unfortunately, for Life Science companies and patients suffering from worsening but treatable chronic disease conditions, that is not how things went down in Q1.

Read more 👉 https://t.co/XzWxM9I5Rr

#arsenaladvisors #LifeScienceCompanies #DigitalMarketing